TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake 
Galp Shares Fall After Q2 EBITDA Miss Despite Profit Beat and Higher Dividend 
CATL Shares Jump as $5.6 Billion Buyback Signals Confidence in Long-Term Growth 
Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns 
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation 
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth 
SK Hynix Q2 Profit Hits Record as AI Memory Chip Demand Fuels Growth 
Brown-Forman Rejects Sazerac’s $15 Billion Takeover Bid as Family Backs Independence 
ASML, Applied Materials Slide as China DUV Chip Equipment Breakthrough Sparks Market Jitters 
Serica Energy to Acquire Pharos Energy for £145.7M, Sending PHARP Shares Soaring 
Barclays Q2 Profit Beats Forecasts as Investment Banking Strength Offsets Higher Costs 
Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth 
Nvidia Eyes $250B Guarantee for OpenAI’s Massive Ohio AI Data Center Project 
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9% 
BHP, Port Hedland Unions Fail to Reach Wage Deal as Negotiations Continue 
Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits 
Seagate Stock Jumps as AI-Fueled Earnings Beat and Strong FY2027 Outlook Impress Investors 
Canada blocked bulk exports of prescription drugs to the US as it would cause or worsen a drug shortage at home.
The said importation from Canada is President Donald Trump's strategy of lowering some drug prices in the US, which he touted in his debate with President-elect Joe Biden.
Many Canadian drug suppliers opposed Trump's plan as it could lead to shortages,
The “Importation Prescription Drugs” rule in the US would allow licensed US pharmacists or wholesalers to import in bulk certain prescription drugs intended for the Canadian market.
According to Canada's Health Minister Patty Hajdu, companies will be required to provide information to assess existing or potential shortages, which could be as quick as within 24 hours if there is a serious or imminent health risk.
Hajdu emphasized the need for vigilance in maintaining the national drug supply noting that Canada is a small market, representing 2 percent of global drug sales, that sources 68 percent of its drugs internationally.
Canadian Prime Minister Justin Trudeau said in September that his priority was protecting the needs of Canadians in terms of pharmaceutical supplies.
